UCLA Hematology/Oncology - Santa Barbara — Santa Barbara, California

UCLA Hematology/Oncology - Santa Barbara is a clinical research site located in Santa Barbara, California, United States 93105.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

UCLA Hematology/Oncology - Santa Barbara has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: HER2 Positive Breast Cancer, Urothelial Carcinoma, Metastatic Castration Sensitive Prostate Cancer (mCSPC).

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematology/Oncology - Santa Barbara?

UCLA Hematology/Oncology - Santa Barbara has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematology/Oncology - Santa Barbara conducted?

UCLA Hematology/Oncology - Santa Barbara has 4 clinical trials on record, with 3 currently active. Their work covers HER2 Positive Breast Cancer, Urothelial Carcinoma, Metastatic Castration Sensitive Prostate Cancer (mCSPC).

Is UCLA Hematology/Oncology - Santa Barbara accredited by Crixeo Health?

UCLA Hematology/Oncology - Santa Barbara has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Hematology/Oncology - Santa Barbara?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.